Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10528)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2016 (publication date) through Dec 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim R, Keam B, Kwon D, Ock CY, Kim M, Kim TM, Kim HJ, Jeon YK, Park IK, Kang CH, Kim DW, Kim YT, Heo DS. Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma. World J Gastroenterol 2016; 22(37): 8389-8397 [PMID: 27729745 DOI: 10.3748/wjg.v22.i37.8389] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i37/8389.htm |
| Number | Citing Articles |
| 1 |
XinCheng He, GaiLi An. Significant role of savolitinib in a case of advanced gastric cancer with abnormal mesenchymal‐epithelial transition factor (MET): A case report. Medicine 2022; 101(48): e32072 doi: 10.1097/MD.0000000000032072
|
| 2 |
Mi Jung Kwon, Kab-Choong Kim, Eun Sook Nam, Seong Jin Cho, Hye-Rim Park, Soo Kee Min, Jinwon Seo, Ji-Young Choe, Hye Kyung Lee, Ho Suk Kang, Kyueng-Whan Min. Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection. Oncotarget 2017; 8(47): 82399 doi: 10.18632/oncotarget.19390
|
| 3 |
Muftah Mahmud, Ananya Munjal, Malvi Savani, Hninyee Win, Umbreen Rozell, Junaid Arshad. Biomarker Testing and Role of Tyrosine Kinase Inhibitors and Immunotherapy for Esophageal Squamous Cell Carcinoma. Foregut: The Journal of the American Foregut Society 2024; 4(4): 467 doi: 10.1177/26345161241238748
|
| 4 |
Nozomi Ito, Hironori Tsujimoto, Hiroyuki Horiguchi, Hideyuki Shimazaki, Hiromi Miyazaki, Daizoh Saitoh, Yoji Kishi, Hideki Ueno. Clinical Significance of Programmed Death Ligand-1 Expression in Esophageal Squamous Cell Carcinoma. Journal of Surgical Research 2020; 251: 321 doi: 10.1016/j.jss.2020.02.013
|
| 5 |
Wei Guo, Fan Zhang, Fei Shao, Pan Wang, Zitong Li, Xueying Yang, Zugen He, Susheng Shi, Yibo Gao, Jie He. PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinoma. Human Pathology 2019; 84: 291 doi: 10.1016/j.humpath.2018.09.014
|
| 6 |
David Vrána, Marcel Matzenauer, Čestmír Neoral, René Aujeský, Radek Vrba, Bohuslav Melichar, Nikol Rušarová, Marie Bartoušková, Janusz Jankowski. From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer. International Journal of Molecular Sciences 2018; 20(1): 13 doi: 10.3390/ijms20010013
|
| 7 |
Wei Guo, Pan Wang, Ning Li, Fei Shao, Hao Zhang, Zhenlin Yang, Renda Li, Yibo Gao, Jie He. Prognostic value of PD-L1 in esophageal squamous cell carcinoma: a meta-analysis. Oncotarget 2018; 9(17): 13920 doi: 10.18632/oncotarget.23810
|
| 8 |
Manoj Kumar Kashyap, Omar Abdel-Rahman. Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0790-4
|
| 9 |
Hyung‑Wook Chun, Ran Hong. Significance of PD‑L1 clones and C‑MET expression in hepatocellular carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10222
|
| 10 |
Weiwei Yu, Yanmei Guo. Prognostic significance of programmed death ligand-1 immunohistochemical expression in esophageal cancer. Medicine 2018; 97(30): e11614 doi: 10.1097/MD.0000000000011614
|
| 11 |
Elisabetta Cavalcanti, Raffaele Armentano, Anna Maria Valentini, Marcello Chieppa, Maria Lucia Caruso. Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading. Cell Death & Disease 2017; 8(8): e3004 doi: 10.1038/cddis.2017.401
|
| 12 |
Parisa Moazzam, Munkhshur Myekhlai, Ali Alinezhad, Fida’a A. Alshawawreh, Padmavathy Bakthavathsalam, Vinicius R Gonçales, Richard D. Tilley, J. Justin Gooding. Ultrasensitive detection of programmed death-ligand 1 (PD-L1) in whole blood using dispersible electrodes. Chemical Communications 2021; 57(20): 2559 doi: 10.1039/D0CC08068C
|
| 13 |
Kohei Yamashita, Masaaki Iwatsuki, Jaffer A. Ajani, Hideo Baba. Programmed death ligand‐1 expression in gastrointestinal cancer: Clinical significance and future challenges. Annals of Gastroenterological Surgery 2020; 4(4): 369 doi: 10.1002/ags3.12348
|
| 14 |
Zhikai Chi, Lan Peng, Dipti M. Karamchandani, Jing Xu. PD-L1 (22C3) expression and prognostic implications in esophageal squamous cell carcinoma. Annals of Diagnostic Pathology 2025; 74: 152394 doi: 10.1016/j.anndiagpath.2024.152394
|
| 15 |
Mi Jung Kwon, Young-Soo Rho, Eun Sook Nam, Seong Jin Cho, Hye-Rim Park, Soo Kee Min, Jinwon Seo, Ji-Young Choe, Eun Soo Kim, Bumjung Park, Mineui Hong, Kyueng-Whan Min. Clinical implication of programmed cell death-1 ligand-1 expression in tonsillar squamous cell carcinoma in association with intratumoral heterogeneity, human papillomavirus, and epithelial-to-mesenchymal transition. Human Pathology 2018; 80: 28 doi: 10.1016/j.humpath.2018.03.025
|
| 16 |
Ranjeet Kumar, Akriti Gupta Jain, Mamoon Ur Rashid, Saeed Ali, Neelam Khetpal, Ishtiaq Hussain, Sarfraz Ahmad. Role of Tyrosine Kinases in Gastrointestinal Malignancies. 2018; : 1 doi: 10.1007/978-981-13-1486-5_1
|
| 17 |
Hong Kyu Lee, Mi Jung Kwon, Yong Joon Ra, Hee Sung Lee, Hyoung Soo Kim, Eun Sook Nam, Seong Jin Cho, Hye-Rim Park, Soo Kee Min, Jinwon Seo, Ji-Young Choe, Kyueng-Whan Min, So Young Kang. Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma. Diagnostic Pathology 2020; 15(1) doi: 10.1186/s13000-020-01045-4
|
| 18 |
Jian Wu, Dawei Zhang, Jun Li, Xin Deng, Guannan Liang, Yang Long, Xuemei He, Tianyang Dai, Delian Ren. MACC1 induces autophagy to regulate proliferation, apoptosis, migration and invasion of squamous cell carcinoma. Oncology Reports 2017; 38(4): 2369 doi: 10.3892/or.2017.5889
|
| 19 |
Ramy R. Saleh, Jordan L. Scott, Nicholas Meti, Danielle Perlon, Rouhi Fazelzad, Alberto Ocana, Eitan Amir. Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis. Molecular Diagnosis & Therapy 2022; 26(2): 153 doi: 10.1007/s40291-022-00576-4
|